|
TW202045161A
|
|
Single-dose packaged clotrimazole liquid composition
|
|
AU2018378981A1
|
|
Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye
|
|
SG11201912393XA
|
|
An oil-in-water nanoemulsion composition of clobetasol
|
|
RS58292B1
|
|
Ophthalmic composition comprising castor oil and medium chain triglyceride
|
|
NZ598125A
|
|
Apaf-1 inhibitor compounds
|
|
EP2366408A1
|
|
Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation
|
|
ES2350077A1
|
|
INHIBITING COMPOUNDS OF 11BETA-HYDROXIESTEROID DEHYDROGENASE TYPE 1.
|
|
ES2335729A1
|
|
COSMETIC COMPOSITION FOR SENSITIVE SKINS.
|
|
EP2065385A1
|
|
Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester
|
|
EP2065707A1
|
|
Detection of endometrial secretion markers for assesment of endometriosis
|
|
EP1994944A1
|
|
Polymer conjugate compounds for the inhibition of apoptosis
|
|
ES2323927A1
|
|
IN VITRO NON-INVASIVE METHOD TO DETECT TRANSITIONAL CARCINOMA OF BLADDER.
|
|
BRPI0706938A2
|
|
dicarbonic compounds with antibacterial activity
|
|
CN101370820A
|
|
Compounds for the inhibition of apoptosis
|
|
US2007276043A1
|
|
Tyrosine derivatives as PPAR-γ-modulators
|
|
ES2138902A1
|
|
"5-aryltio-6-sulfonamido-3 (2h) -benzofuranonas as cox-2 inhibitors".
|
|
ES2088742A1
|
|
Antibiotic composition of otic application.
|
